Anti-tumor effect of β-elemene in murine hepatocellular carcinoma cell line H22 depends on the level of c-Met downregulation

Biomedicine and Preventive Nutrition

Volumn 2, Issue 2, 2012, Pages 91-98

  Qin, Yan ^a   Guo, Yunjun ^a   Wei, Wei ^a   Wang, Bo ^a   Jin, Hongfei ^a   Sun, Jianguo ^a   Qi, Xia ^a   Ren, Shuangyi ^a   Zuo, Yunfei ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

elemene; C Met; H22 cells

Indexed keywords

BETA ELEMENE; FLUOROURACIL; SCATTER FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER SIZE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; GENE EXPRESSION REGULATION; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

MURINAE; ZINGIBER OFFICINALE;

EID: 84862815628     PISSN: 22105239     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bionut.2012.01.005     Document Type: Article

References (46)

1. Sawey E.T., Chanrion M., Cai C., Wu G., Zhang J., Zender L., et al. Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by oncogenomic screening. Cancer Cell 2011, 19:347-358.
2. Ueki T., Fujimoto J., Suzuki T., Yamamoto H., Okamoto E. Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma. Hepatology 1997, 25:862-866.
3. Kaposi-Novak P., Lee J.S., Gomez-Quiroz L., Coulouarn C., Factor V.M., Thorgeirsson S.S. Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype. J Clin Invest 2006, 116:1582-1595.
4. Ke A.W., Shi G.M., Zhou J., Wu F.Z., Ding Z.B., Hu M.Y., et al. Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma. Hepatology 2009, 49:491-503.
5. Zou L., Liu W., Yu L. Beta-elemene induces apoptosis of K562 leukemia cells. Zhonghua Zhong Liu Za Zhi 2001, 23(3):196-198.
6. Zhou H., Shen J., Hou J., Qiu Y., Luo Q. Experimental study on apoptosis induced by elemene in glioma cells (in Chinese). Ai Zheng 2003, 22:959-963.
7. Yang H., Wang X., Yu L., Zheng S. Study on the anticancer mechanism of elemene (in Chinese). Chin. Clin. Cancer 1999, 26:4-7.
8. Li X., Wang G., Zhao J., Ding H., Cunningham C., et al. Antiproliferative effect of beta-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase. Cell Mol Life Sci 2005, 62:894-904.
9. Wang G., Li X., Huang F., Zhao J., Ding H., et al. Antitumor effect of beta-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death. Cell Mol Life Sci 2005, 62:881-893.
10. Wang Y., Deng Y., Mao S., Jin S., Wang J., et al. Characterization and body distribution of beta-elemene solid lipid nanoparticles (SLN). Drug Dev Ind Pharm 2005, 31:769-778.
11. Zheng S., Yang H., Zhang S., Wang X., Yu L., Lu J., et al. Initial study on naturally occurring products from traditional Chinese herbs and vegetables for chemoprevention. J Cell Biochem Suppl 1997, 27:106-112.
12. Birchmeier C., Birchmeier W., Gherardi E., VandeWoude G.F. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003, 4:915-925.
13. Corso S., Comoglio P.M., Giordano S. Cancer therapy: can the challenge be MET?. Trends Mol Med 2005, 11:284-292.
14. Rong S., Segal S., Anver M., Resau J.H., Vande Woude G.F. Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc Natl Acad Sci U S A 1994, 91:4731-4735.
15. Takayama H., LaRochelle W.J., Sharp R., Otsuka T., Kriebel P., Anver M., et al. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci U S A 1997, 94:701-706.
16. Wang R., Ferrell L.D., Faouzi S., Maher J.J., Bishop J.M. Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice. J Cell Biol 2001, 153:1023-1034.
17. Nagayama T., Nagayama M., Kohara S., Kamiguchi H., Shibuya M., Katoh Y., et al. Post-ischemic delayed expression of hepatocyte growth factor and c-Met in mouse brain following focal cerebral ischemia. Brain Res 2004, 999:155-166.
18. Benvenuti S., et al. The Met receptor tyrosine kinase in invasion and metastasis. J Cell. Physiol 2007, 213:316-325.
19. Fang N., Chen D.X., Wang H.Y. Effect of β-Elemene in inducing liver carcinoma cell apoptosis and its mechanism. Chinese J Integr Tradit West Med 2002, 6:190-192.
20. Qi X.J., Wang F. Effect of TACE with β-elemene and lipiodol on apoptosis and proliferation of VX2 carcinoma of rabbits. Chinese J Interven Radiol 2008, 2:358-361.
21. Yao S.J., Liu B.Y., Zhong Z.H. Experimental study of anti-tumor effect of ELE on liver cancer. J Qiqi-har Med College 2006, 27:257-258.
22. Wang X.S., Yang W., Tao S.J., Li K., Li M., Dong J.H., et al. The effect of delta-elemene on Hela cell lines by apoptosis induction. Yakugaku Zasshi 2006, 126(10):979-990.
23. Yuan J., Gu Z.L., Chou W.H., Kwok C.Y. Elemene induces apoptosis and regulates expression of bcl-2 protein in human leukemia K562 cells. Zhongguo Yao Li Xue Bao 1999, 20(2):103-106.
24. Tao L., Zhou L., Zheng L., Yao M. Elemene displays anticancer ability on laryngeal cancer cells in vitro and in vivo. Cancer Chemother Pharmacol 2006, 58(1):24-34.
25. Yao Y.Q., Ding X., Jia Y.C., Huang C.X., Wang Y.Z. Antitumor effect of beta-elemene in glioblastoma cells depends on p38 MAPK activation. Cancer Lett 2008, 264:127-134.
26. Cerard E., Trevor L. A matter of life and cell death. Science 1998, 281(5381):1317-1322.
27. Wang Y., Fang M.Y., Jiang F., Peng H.J. Effects of arsenic trioxide, ginseng saponin and beta-elemene on telomere-telomerase system in K562 cell line. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2004, 12:315-320.
28. Xu Y.H., Dong B., Luo Q.Z., Zhou H.Y., Jia Y.C. Influence of elemene on the expression of Bcl-2 family genes in rat C6 glioma cells. Zhonghua Yi Xue Za Zhi 2005, 85:1700-1703.
29. Kerbel R.S. Tumor angiogenesis. N Engl J Med 2008, 358:2039-2049.
30. Streit M., Detmar M. Angiogenesis, lymphangiogenesis, and melanoma metastasis. Oncogene 2003, 22:3172-3179.
31. Van Hinsbergh V.W.M., Collen A., Koolwijk P. Role of fibrin matrix in angiogenesis. Ann NY Acad Sci 2001, 936:426-437.
32. Chen W., Lu Y., Wu J., Gao M., Wang A., Xu B. Beta-elemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factor-mediated angiogenesis. Cancer Chemother Pharmacol 2011, 67:799-808.
33. Maulik G., Shrikhande A., Kijima T., Ma P.C., Morrison P.T., Salgia R. Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev 2002, 13:41-59.
34. Garcia S., Dales J.P., Charafe-Jauffret E., Carpentier-Meunier S., Andrac-Meyer L., Jacquemier J., et al. Overexpression of c-Met and of the transducers PI3K, FAK and JAK in breast carcinomas correlates with shorter survival and neoangiogenesis. Int J Oncol 2007, 31:49-58.
35. Puri N., Ahmed S., Janamanchi V., Tretiakova M., Zumba O., Krausz T., et al. c-Met is a potentially new therapeutic target for treatment of human melanoma. Clin Cancer Res 2007, 13:2246-2253.
36. Grant D.S., Kleinman H.K., Goldberg I.D., Bhargava M.M., Nickoloff B.J., Kinsella J.L., et al. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad. Sci. U S A 1993, 90:1937-1941.
37. Ding S., Merkulova-Rainon T., Han Z.C., Tobelem G. HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro. Blood 2003, 101:4816-4822.
38. Zhang Y.W., Su Y., Volpert O.V., Vande Woude G.F. Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. Proc Natl Acad. Sci. U S A 2003, 100:12718-12723.
39. You W.K., McDonald D.M. The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis. BMB Rep 2008, 41(12):833-839.
40. Longati P., Bardelli A., Ponzetto C., Naldini L., Comoglio P.M. Tyrosines1234-1235 are critical for activation of the tyrosine kinase encoded by the MET proto-oncogene (HGF receptor). Oncogene 1994, 9:49-57.
41. Zhu H., Naujokas M.A., Fixman E.D., Torossian K., Park M. Tyrosine 1356 in the carboxyl-terminal tail of the HGF/SF receptor is essential for the transduction of signals for cell motility and morphogenesis. J Biol Chem 1994, 269:29943-29948.
42. Ponzetto C., Bardelli A., Zhen Z., Maina F., dalla Zonca P., Giordano S., et al. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell 1994, 77:261-271.
43. Ponzetto C., Bardelli A., Maina F., Longati P., Panayotou G., Dhand R., et al. A novel recognition motif for phosphatidylinositol 3-kinase binding mediates its association with the hepatocyte growth factor/scatter factor receptor. Mol Cell Biol 1993, 13:4600-4608.
44. Comoglio P.M., Giordano S., Trusolino L. Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nat Rev Drug Discov 2008, 7:504-516.
45. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAPkinases on apoptosis. Science 1995, 270(5240):1326-1331.
46. Chen G., Hitomi M., Han J., Stacey D.W. The p38 pathway provides negative feedback for Ras proliferative signaling. J Biol Chem 2000, 275(50):38973-38980.